Radiotherapie stereotaxique des metastases cerebrales: experience lausannoise. [Stereotaxic radiotherapy of brain metastases: experiences in Lausanne]
Détails
ID Serval
serval:BIB_A2AB8888DB34
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Radiotherapie stereotaxique des metastases cerebrales: experience lausannoise. [Stereotaxic radiotherapy of brain metastases: experiences in Lausanne]
Périodique
Schweizerische Medizinische Wochenschrift
ISSN
0036-7672 (Print)
Statut éditorial
Publié
Date de publication
10/1997
Volume
127
Numéro
40
Pages
1652-6
Notes
English Abstract
Journal Article --- Old month value: Oct 4
Journal Article --- Old month value: Oct 4
Résumé
We report the first series of patients treated by stereotactic radiation therapy for brain metastases in Switzerland. From August 1993 to December 1994, 19 patients were treated using a linear accelerator adapted for stereotactic treatment set-up. Most of the patients received combined treatment including external irradiation. The crude overall control rate for brain metastases was 79%. Median survival was 12.2 months. Overall survival at one year was 50 +/- 12%. These data compare reasonably well with the reported median survival of 3-6 months using external cranial irradiation alone. There was no "late toxicity". The data thus indicate that stereotactic radiation therapy combined with external whole brain irradiation appears to increase life expectancy and quality of life in a selected cohort of patients.
Mots-clé
Actuarial Analysis
Adult
Aged
Aged, 80 and over
Brain Neoplasms/mortality/radiotherapy/*secondary/surgery
Combined Modality Therapy
Female
Follow-Up Studies
Humans
Male
Middle Aged
*Radiosurgery
Radiotherapy, Adjuvant
Survival Rate
Pubmed
Web of science
Création de la notice
24/01/2008 18:20
Dernière modification de la notice
20/08/2019 16:08